In this presentation, Nathan S. Bryan will provide an overview of the atmospheric and human nitrogen cycles and nitric oxide production pathways in humans. He will review evidence based nitric oxide research specific to vascular function and structure. In addition to nitric oxide production, he will review the importance of nitrate and how much is recommended daily for health benefits. Dr. Bryan will also discuss nitric oxide therapeutic interventional outcome data and how to control and regulate nitric oxide production

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

1. Recognize nitric oxide production pathways in humans.
2. Demonstrate evidence on how NO affects vascular structure and function.
3. Communicate evidence based nutritional strategies to restore and replete NO production in humans to restore vascular structure and function.

To continue select your profession.

This presentation will address the burden of Alzheimer’s disease in the United States and the role of amyloid beta in the progression of this disease. You will be given the tools to help prevent Alzheimer’s disease through lifestyle medicine and modification.

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

1. Outline the burden of Alzheimer’s disease in the United States.
2. Describe the role that the lipid-binding protein APoE4 plays in modifying the risk of Alzheimer’s disease.
3. List at least two normal roles for amyloid beta in the brain.
4. Describe the solutions lifestyle medicine provides to address the burden of Alzheimer’s disease.

To continue select your profession.

It is estimated that each day more than 1000 people are treated in emergency departments for not using prescription opioids as prescribed. Combine this with illicit drug use and the cost of treatment and productivity losses related to addiction and we have a current epidemic costing Americans over 500 billion dollars and rising.

This interactive course will give the participant the resources and tools necessary to identify, educate and treat opioid tolerant and opioid addicted patients in primary care. We will cover the pathophysiology of opioids and their receptors, then we will transition to discussing tolerance vs. withdrawal and addiction. We will also review overdose antagonist medications, medication assisted treatments as well as briefly discuss new treatments and research on the horizon.

Outcome Objectives:
Upon completion of this CME/CE activity the healthcare provider will be able to:

1. Describe the pathophysiology of opioid receptors in the reward pathway and how different opioids and opioid antagonists interact and bind to these receptors.
2. Describe the common clinical features of chronic opioid abuse and suspected opioid withdrawal including appropriate diagnostic work-up.
3. Discuss the current best practice treatment options for suspected opioid overdose including routes of administration and formulations as well as medication assisted treatment options.
4. Identify new or emerging areas of research and treatment options for opioid dependence including pharmacologic and psychosocial strategies.

To fully participate in this activity you must be Registered and Logged In to this website.

To continue select your profession.

The goal of this course is to provide the knowledge and tools to equip the Primary Care Provider, Pharmacist and Other Health Care Providers to improve the health status of patients with Heart Failure. It includes an audience participated Q&A session and ends with a description of a 20 credit hour Performance Improvement Project and an invitation and instructions to enroll in this project without cost.

Outcome Objective
Upon completion of this CME/CE activity the healthcare provider will be able to:

1. Describe the clinical epidemiology of heart failure and its impact on health care delivery and costs.
2. Distinguish heart failure with reduced left ventricular function from heart failure with preserved ventricular function.
3. Explain the pathophysiological processes that occur to create clinical heart failure and promote its progression.
4. Identify pharmacological and non-pharmacologic approaches to treating patients with heart failure and a step-wise approach to their implementation.
5. Utilize the provider and patient toolkits to better educate patients about this condition and steps they can take to avoid it for better health outcomes.

To continue select your profession.